ACER — Acer Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-UGI, SkyWest, Sage Therapeutics
Acer Therapeutics surges on Zevra buyout deal
Brief: Zevra Therapeutics To Acquire Acer Therapeutics, Expanding Its Rare Disease Portfolio And Adding Commercial Product
Swiss stocks - Factors to watch on August 31
Acer Therapeutics gains after re-acquiring drug rights
Brief: Acer Therapeutics Reacquires Worldwide Development, Commercialization & Economic Rights To OLPRUVA From Relief Therapeutics
Brief: Relief Therapeutics Announces New Exclusive Definitive License Agreement For Olpruva With Acer Therapeutics
Acer Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Acer Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Acer Therapeutics Receives $1 Million Capital Infusion From Chief Executive Officer And Founder
Brief: Acer Therapeutics Receives Notice Of Delisting Or Failure From Nasdaq
Acer Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Acer Therapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview
Brief: Acer Therapeutics Inc Says On May 3, Co Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq
Brief: Acer Therapeutics Announces Olpruva Commercial Launch Progressing Ahead Of Schedule
Brief: Relief Therapeutics Says Olpruva Commercial Launch Progressing Ahead Of Schedule
Acer Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Acer Therapeutics Reports Q4 Results
Brief: Acer Therapeutics Announces $2.675 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules